TELA Bio (TELA) Gross Profit (2018 - 2026)

TELA Bio's Gross Profit history runs 9 years deep, the most recent figure standing at $12.5 million for Q1 2026.

• In Q1 2026, Gross Profit changed 0.06% year-over-year to $12.5 million; the TTM figure through Mar 2026 stood at $54.3 million (up 14.03% YoY), while the FY2025 annual figure was $54.3 million, up 16.89% from the prior year.
• Gross Profit was $12.5 million for Q1 2026 at TELA Bio, down from $13.8 million in the prior quarter.
• In the past five years, Gross Profit ranged from a high of $14.1 million in Q2 2025 to a low of $5.0 million in Q1 2022.
• Historically, Gross Profit has averaged $10.6 million across 5 years, with a median of $11.2 million in 2024.
• The sharpest annual moves came in 2022 and 2024: Gross Profit surged 59.04% in 2022, then dropped 3.47% in 2024.
• A 5-year view of Gross Profit shows it stood at $8.2 million in 2022, then jumped by 42.17% to $11.6 million in 2023, then slipped by 3.47% to $11.2 million in 2024, then increased by 22.58% to $13.8 million in 2025, then declined by 8.98% to $12.5 million in 2026.
• The last three Gross Profit figures came in at $12.5 million (Q1 2026), $13.8 million (Q4 2025), and $14.0 million (Q3 2025), per Business Quant data.